Teachers Advisors’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Teachers Advisors’s Portfolio CASC Stock Details CASC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-61,621	Closed	-$228K	–	3077
2017 Q4	$228K	Hold	61,621	–	–	﹤0.01%	2894
2017 Q3	$252K	Sell	61,621 -6,219	-9%	-$23.8K	﹤0.01%	2913
2017 Q2	$252K	Buy	+67,840	New	+$269K	﹤0.01%	2936
2016 Q2	–	Sell	-25,857	Closed	-$197K	–	3204
2016 Q1	$197K	Hold	25,857	–	–	﹤0.01%	2801
2015 Q4	$344K	Hold	25,857	–	–	﹤0.01%	2621
2015 Q3	$425K	Buy	25,857 +1,139	+5%	+$23.4K	﹤0.01%	2489
2015 Q2	$555K	Buy	24,718 +2,981	+14%	+$47.2K	﹤0.01%	2469
2015 Q1	$213K	Buy	21,737 +5,377	+33%	+$52.7K	﹤0.01%	2861
2014 Q4	$187K	Hold	16,360	–	–	﹤0.01%	2925
2014 Q3	$188K	Hold	16,360	–	–	﹤0.01%	2914
2014 Q2	$318K	Buy	+16,360	New	+$289K	﹤0.01%	2704

Teachers Advisors's CASC Position: Q1 2018 in Review

Teachers Advisors sold out of Cascadian Therapeutics, Inc. (CASC) in Q1 2018, closing a stake of 61,621 shares — an estimated $228K sold.

Teachers Advisors first reported a position in CASC in Q2 2014 and held it in 11 quarters. The position peaked at $555K in Q2 2015. 1 fund tracked by Wall St. Rank holds CASC as of Q1 2018.

Teachers Advisors reported no remaining Cascadian Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Teachers Advisors sold 61,621 Cascadian Therapeutics, Inc. shares in Q1 2018, an estimated $228K.
Teachers Advisors first reported a position in Cascadian Therapeutics, Inc. in Q2 2014 and held it in 11 quarters.
Teachers Advisors's Cascadian Therapeutics, Inc. position peaked at $555K in Q2 2015.
1 fund tracked by Wall St. Rank held Cascadian Therapeutics, Inc. as of Q1 2018.

Based on Teachers Advisors's 13F filing for Q1 2018, filed 14 May 2018.